COVID-19 mortality – Page 13 – Communicable Diseases Research

Red flags of poor prognosis in pediatric cases of COVID-19: the first 6610 hospitalized children in Iran

Research

Published on 2021-12-102022-10-28
Journal: BMC Pediatrics [Category] COVID-19, SARS,

[키워드] approved cardiovascular children children with COVID-19 chronic chronic pulmonary disease Clinical course co-morbidities co-morbidity Confirmed COVID-19 infection cough COVID-19 COVID-19 infection COVID-19 mortality cross-sectional death Diabetes Mellitus disease Dyspnea effective Epidemiology evaluated group Hospitalization Hospitalized hospitalized COVID-19 ICU admission Infant Infection introduced Iran Kidney disease Laboratory male Mortality mortality rate National Pediatric case Pediatrician poor prognosis positive presenting Red regimen Result risk factor significantly higher supplementary material Symptom therapeutic
[DOI] 10.1186/s12887-021-03030-2 PMC 바로가기 [Article Type] Research

Disparities in COVID-19 infection, hospitalisation and death in people with schizophrenia, bipolar disorder, and major depressive disorder: a cohort study of the UK Biobank

Research

Published on 2021-12-072022-10-05
Journal: Molecular Psychiatry [Category] 바이오마커,

The Impact of COVID-19 on Mortality in Spain: Monitoring Excess Mortality (MoMo) and the Surveillance of Confirmed COVID-19 Deaths

코비드 -19가 스페인의 사망률에 미치는 영향 : 초과 사망률 모니터링 (MOMO) 및 확인 된 CovID-19 사망의 감시

Article

Published on 2021-12-032022-09-10
Journal: Viruses [Category] SARS, 치료기술,

Estimating the impact of influenza on the epidemiological dynamics of SARS-CoV-2

Mathematical Biology

Published on 2021-12-032022-10-28
Journal: PeerJ [Category] COVID-19,

[키워드] acute respiratory syndrome assumption average Belgium caused coronavirus coronavirus disease COVID-19 COVID-19 mortality effective epidemic of COVID-19 epidemiological Epidemiology estimate Europe European country Evidence experimental evidence expression facilitate highlight Hypothesis impacted incidence increase in indicate Influenza influenza infection Italy mathematical modeling measure Measures Mortality Norway Pandemics pathogen receptor remained required robust SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 transmission Spain Spread statistical up-regulate variety virus–virus interaction
[DOI] 10.7717/peerj.12566 PMC 바로가기 [Article Type] Mathematical Biology

Establishing an ad hoc COVID-19 mortality surveillance during the first epidemic wave in Belgium, 1 March to 21 June 2020

2020년 3월 1일부터 6월 21일까지 벨기에의 첫 번째 전염병 유행 기간 동안 임시 COVID-19 사망률 감시 설정

Surveillance

Published on 2021-12-022022-09-10
Journal: Eurosurveillance [Category] SARS, 치료기술,

Association of COVID-19 mortality with politics and on-demand testing in 217 U.S. counties

Research

Published on 2021-12-022022-10-28
Journal: BMC Public Health [Category] COVID-19, SARS,

A comparison between virus- versus patients-centred therapeutic attempts to reduce COVID-19 mortality

COVID-19 사망률을 줄이기 위한 바이러스 중심 치료와 환자 중심 치료 간의 비교

Review

Published on 2021-12-012022-09-10
Journal: Emerging Microbes & Infections [Category] SARS, 치료제,

[키워드] ACE2 acute respiratory disease acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 aging angiotensin angiotensin converting enzyme angiotensin converting enzyme 2 anti-inflammatory treatment anti-inflammatory treatments Antiviral antivirals bind caused changed Comorbidities coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 mortality death rate death rates Dexamethasone dysfunction Effectiveness effort elderly elderly patients enzyme explain hospitalized COVID-19 patient hospitalized COVID-19 patients hospitalized patient hospitalized patients Infection inhibit limit majority Mas receptor Mortality Patient patients patients hospitalized reduce Renin renin-angiotensin system replicative required respiratory Respiratory failure SARS-CoV-2 SARS-CoV-2 viral load Scientific community severe acute respiratory syndrome Coronavirus severe COVID-19 symptoms severity severity of symptom Spike protein syndrome the disease the spike protein therapeutic therapeutic option therapeutic options therapeutic strategy those with comorbidity Tocilizumab Treatment Viral Viral load virus with COVID-19
[DOI] 10.1080/22221751.2021.2006579 PMC 바로가기 [Article Type] Review

Epidemiology and Risk Factors of COVID-19-Related Mortality

Internal Medicine

Published on 2021-12-012022-10-31
Journal: Cureus [Category] COVID-19,

[키워드] Admission analyzed Characteristics Clinical characteristics Clinical findings Comorbidities Comorbidity conducted coronavirus disease Course COVID-19 COVID-19 confirmed patients COVID-19 India COVID-19 mortality COVID-19 patient COVID-19 severity demographic characteristics demographics Department diabete diabetes and hypertension Diabetes Mellitus epidemiological epidemiology and public health Factor Final greater hospital hospitalized COVID-19 patients hypertension identify IMV India intensive care Intervention Invasive mechanical ventilation laboratory data laboratory parameter less Logistic regression analysis Lower Medical Sciences Medicine Mortality multivariate need for oxygen New NIV non-invasive ventilation outcomes oxygen saturation oxygen supplementation pandemic Patient performed predictors presence of comorbidities prognostic Result retrospective risk-factors serum creatinine severe disease Systolic blood pressure the patient therapy Vaccination strategies
[DOI] 10.7759/cureus.20072 PMC 바로가기 [Article Type] Internal Medicine

Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review

Review

Published on 2021-12-012022-10-28
Journal: BMC Medicine [Category] COVID-19, SARS,

COVID-19 hospital admissions and deaths after BNT162b2 and ChAdOx1 nCoV-19 vaccinations in 2·57 million people in Scotland (EAVE II): a prospective cohort study

BNT162B2 및 Chadox1 NCOV-19 백신 접종 후 COVID-19 병원 입원 및 사망 (EAVE II) : 전향 적 코호트 연구

Articles

Published on 2021-12-012022-09-06
Journal: The Lancet. Respiratory Medicine [Category] Communicable Disease, COVID-19, Fulltext, SARS,

[키워드] (Medical Research Council) 95% CI adjusted Admission Analysis BNT162b2 Care ChAdOx1 ChAdOx1 nCoV-19 challenge clinical factor clinical feature Comorbidities Comorbidity conducted COVID-19 COVID-19 hospitalisation COVID-19 illness COVID-19 mortality COVID-19 test COVID-19 vaccination programme COVID-19 vaccine death died enhanced estimate rate ratio finding first dose FIVE Frequency funding group Health Data Research UK help highest hospital Hospital admission hospitalisation hospitalised incidence individual individuals Industrial Innovation less male management Medical Research Council Mortality National Older age outcome pandemic Pfizer Pfizer–BioNTech platform Poisson regression model primary care prioritised vaccination prospective cohort study Protective rate ratios receiving risk risk of COVID-19 RRs RT-PCR testing SARS-COV-2 infection Scottish severe COVID-19 severe disease Social distancing measure social distancing measures Socioeconomic deprivation Strategy stratified study period Surveillance time-dependent Poisson regression model unvaccinated population unvaccinated populations vaccination Vaccine vaccine dose with COVID-19
[DOI] 10.1016/S2213-2600(21)00380-5 PMC 바로가기 [Article Type] Articles